Increasing evidence suggests that the downregulation of FAT4 may be associated with the progression of several malignant carcinomas, including breast cancer, colorectal cancer, and gastric cancer.7, 8, 9, 10, 11, 12, 13. The gene discussed is FAT4; the disease is colorectal cancer.